According to BioMarin Pharmaceutical's latest financial reports the company's total liabilities are ยฃ1.16 Billion. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | ยฃ1.48 B | 1.29% |
2022-12-31 | ยฃ1.46 B | 13.68% |
2021-12-31 | ยฃ1.28 B | 0.81% |
2020-12-31 | ยฃ1.27 B | 6.9% |
2019-12-31 | ยฃ1.19 B | 4% |
2018-12-31 | ยฃ1.14 B | -14.84% |
2017-12-31 | ยฃ1.34 B | 32.47% |
2016-12-31 | ยฃ1.01 B | 13.67% |
2015-12-31 | ยฃ0.89 B | 47.31% |
2014-12-31 | ยฃ0.60 B | 11.17% |
2013-12-31 | ยฃ0.54 B | 60.13% |
2012-12-31 | ยฃ0.34 B | -0.24% |
2011-12-31 | ยฃ0.34 B | -2.99% |
2010-12-31 | ยฃ0.35 B | -3.92% |
2009-12-31 | ยฃ0.36 B | -14.47% |
2008-12-31 | ยฃ0.42 B | 36.08% |
2007-12-31 | ยฃ0.31 B | 79.02% |
2006-12-31 | ยฃ0.17 B | 11.56% |
2005-12-31 | ยฃ0.15 B | 0.9% |
2004-12-31 | ยฃ0.15 B | 102.48% |
2003-12-31 | ยฃ77.41 M | 928.18% |
2002-12-31 | ยฃ7.52 M | -10.97% |
2001-12-31 | ยฃ8.45 M |